NCT02567162

Brief Summary

The aim of this project is development of a comprehensive, prospective, multinational, multicenter, hospital-based, data repository for patients with intracerebral hemorrhage.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2015

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 2, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

December 9, 2016

Status Verified

December 1, 2016

Enrollment Period

9 months

First QC Date

September 30, 2015

Last Update Submit

December 8, 2016

Conditions

Keywords

Intracerebral hemorrhageHemorrhagic strokeIntraparenchymal hemorrhageCerebrovascular diseaseStroke

Outcome Measures

Primary Outcomes (1)

  • Modified Rankin Scale score

    90 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized for ICH will be asked to provide their permission for the use of this information for retrospective research studies directed at ICH; such research to be conducted by the MNEMONICH investigators.

You may qualify if:

  • Diagnosis of spontaneous intracerebral hemorrhage (ICH) met by clinical and imaging criteria
  • Age 18 and above
  • Able to consent

You may not qualify if:

  • ICH due to trauma
  • ICH due to vascular malformation or aneurysm
  • ICH due to brain tumor
  • ICH due to underlying infectious lesion (e.g., abscess)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Behrouz R, Azarpazhooh MR, Godoy DA, Hoffmann MW, Masotti L, Parry-Jones AR, Popa-Wagner A, Schreuder FH, Slevin MA, Smith CJ, Di Napoli M; MNEMONICH Steering Committee. The Multi-National survey on Epidemiology, Morbidity, and Outcomes iN Intracerebral Haemorrhage (MNEMONICH). Int J Stroke. 2015 Dec;10(8):E86. doi: 10.1111/ijs.12629. No abstract available.

    PMID: 26745705BACKGROUND

MeSH Terms

Conditions

Cerebral HemorrhageHemorrhagic StrokeCerebrovascular DisordersStroke

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Mario Di Napoli, MD

    Centre for Cardiovascular Medicine and Cerebrovascular Disease Prevention

    STUDY DIRECTOR
  • Mahmoud R Azarpazhooh, MD

    Western University, Canada

    PRINCIPAL INVESTIGATOR
  • Reza Behrouz, DO

    The University of Texas Health Science Center at San Antonio

    PRINCIPAL INVESTIGATOR
  • Luca Masotti, MD

    Azienda USL Reggio Emilia - IRCCS

    PRINCIPAL INVESTIGATOR
  • Adrian R Parry-Jones, MBChB, PhD

    University of Manchester and the Salford Royal NHS Foundation Trust

    PRINCIPAL INVESTIGATOR
  • Aurel Popa-Wagner, MD, PhD

    University of Rostock

    PRINCIPAL INVESTIGATOR
  • Mark A Slevin, PhD

    Manchester Metropolitan University

    PRINCIPAL INVESTIGATOR
  • Craig J Smith, MBChB, MD

    University of Manchester and the Salford Royal NHS Foundation Trust

    PRINCIPAL INVESTIGATOR
  • Daniel A Godoy, MD

    Hospital Interzonal de Agudos San Juan Bautista

    PRINCIPAL INVESTIGATOR
  • Floris H Schreuder, MD

    Maastricht University Medical Center

    PRINCIPAL INVESTIGATOR
  • Michael W Hoffmann, MBChB, PhD

    University of Central Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
90 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 30, 2015

First Posted

October 2, 2015

Study Start

November 1, 2015

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

December 9, 2016

Record last verified: 2016-12